Literature DB >> 6296243

Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.

A Z Kapikian, R G Wyatt, M M Levine, R H Yolken, D H VanKirk, R Dolin, H B Greenberg, R M Chanock.   

Abstract

Four of 18 volunteers challenged orally with human rotavirus strain D (subgroup 2, serotype Wa) developed a diarrheal illness two to four days after inoculation. Viral shedding was detected in five of the 18 volunteers, whereas 12 (67%) developed serologic evidence of infection. Two volunteers who developed diarrheal illness after the initial inoculation were given the same inoculum 19 months later; neither developed diarrhea, although one developed constitutional and gastrointestinal symptoms. The presence of preinoculation serum immunofluorescent antibody to rotavirus strain D or high levels of neutralizing antibody to Wa or reassortant DS-1 human rotavirus correlated with resistance to diarrheal illness. Although prechallenge serum antibody correlated with resistance to diarrhea and/or shedding of rotavirus, the relationship of preexisting local neutralizing activity in intestinal fluid was less clear-cut.

Entities:  

Mesh:

Year:  1983        PMID: 6296243     DOI: 10.1093/infdis/147.1.95

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Rotavirus-specific T-cell responses in young prospectively followed-up children.

Authors:  M Mäkelä; J Marttila; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

2.  An age-structured epidemic model of rotavirus with vaccination.

Authors:  E Shim; Z Feng; M Martcheva; C Castillo-Chavez
Journal:  J Math Biol       Date:  2006-08-17       Impact factor: 2.259

3.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Measurement of rotavirus-neutralizing coproantibody in children by fluorescent focus reduction assay.

Authors:  B S Coulson; P J Masendycz
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 5.  Development of rotavirus vaccines.

Authors:  R E Black; C Lanata
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

6.  Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization.

Authors:  I de Zoysa; R G Feachem
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

7.  Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection.

Authors:  P A Offit; S L Cunningham; K I Dudzik
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  A murine model for oral infection with a primate rotavirus (simian SA11).

Authors:  P A Offit; H F Clark; M J Kornstein; S A Plotkin
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

9.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

10.  Protection of agammaglobulinemic piglets from porcine rotavirus infection by antibody against simian rotavirus SA-11.

Authors:  J G Lecce; H L Leary; D A Clarke; R P Batema
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.